• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    LifeWallet Announces a New Pharmaceutical Antitrust Settlement Totaling $3.1 Million

    8/19/24 2:00:24 AM ET
    $LIFW
    $PLTR
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $LIFW alert in real time by email

    CORAL GABLES, Fla., Aug. 19, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ:LIFW) ("LifeWallet" or "the Company") announces a new pharmaceutical antitrust settlement in the amount of $3.1 million.

    • Company also announces a drive to secure agreements with health plans, property & casualty insurers, attorneys, and healthcare providers, including hospital systems
    • This subscription licensing is expected to generate revenue through fees charged on savings from unnecessary Medicare secondary payments
    • This is all part of LifeWallet's clearinghouse system, through its exclusive healthcare partnership with Palantir Technologies, Inc.

    Details of the Settlement

    MSP Recovery Law Firm LLC, acting on behalf of LifeWallet, alleged that the manufacturer had increased the price of a drug in violation of antitrust laws. The settlement is in the amount of $3.1 million, which is expected to be collected in the third quarter of 2024.

    As part of LifeWallet's owned claims portfolio, the Company has claims against pharmaceutical and medical device manufacturers based on allegations of defective products or anti-competitive pricing. LifeWallet has ongoing claims against multiple manufacturers.

    LifeWallet is also currently in negotiations with multiple other property & casualty (P&C) insurers to resolve claims as well as negotiating with other product manufacturers on both pharmaceutical products as well as medical device cases. LifeWallet notes these settlements are not a guarantee that LifeWallet's portfolio of assigned claims (owed by other Primary Payers1 and manufacturers) can be settled with the same or similar terms.

    LifeWallet/Palantir Clearinghouse Solution

    LifeWallet has implemented a drive to secure agreements with health plans, property and casualty insurers, attorneys, and healthcare providers, including hospital systems. This subscription licensing is expected to generate revenue through fees charged on savings from unnecessary Medicare secondary payments. This is all part of LifeWallet's clearinghouse system, through its exclusive healthcare partnership with Palantir Technologies, Inc. (NYSE:PLTR), enhancing LifeWallet's Chase to Pay model. The clearinghouse solution utilizes the Palantir Foundry platform, AI tools, natural language processing, and machine learning, resulting in the development of a sophisticated data analytics system that captures and manages healthcare data.

    The LifeWallet/Palantir clearinghouse builds upon previously announced initiatives ("MSP Recovery and Palantir to Transform Connectivity Across the U.S. Healthcare System") providing real-time data driven solutions that focus on data from patients, attorneys, healthcare providers, and healthcare insurers, as well as property and casualty insurers, all designed to build an expansive repository of data that can be used to determine medical conditions as well as payer obligations.

    The system was instrumental in the recent class certification in June 2024 against USAA Property and Casualty Company, exemplifying the breadth and depth of the systemic issues plaguing the healthcare system.  

    LifeWallet's CEO John H. Ruiz commented, "We continue taking steps in the right direction, advancing projects that could provide a steady stream of revenue, in addition to the litigation model that oftentimes takes years to materialize."

    Forward Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, including for example statements regarding potential future settlements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by the Company herein speaks only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for the Company to predict or identify all such events or how they may affect it. the Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, the Company's ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; the inherent uncertainty surrounding settlement negotiations and/or litigation, including with respect to both the amount and timing of any such results; the success of the Company's scheduled settlement mediations; the validity of the assignments of claims to the Company; negative publicity concerning healthcare data analytics and payment accuracy; and those other factors included in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

    About LifeWallet

    Founded in 2014 as MSP Recovery, LifeWallet has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries from responsible parties. LifeWallet provides comprehensive solutions for multiple industries including healthcare, legal, education, and sports NIL. For more information, visit: LIFEWALLET.COM

    ________________________

    1 "Primary Plans" or "Primary Payers," when used in the Medicare Secondary Payer context, means "any entity that is or was required or responsible to make payment with respect to an item or service (or any portion thereof) under a primary plan. These entities include, but are not limited to, insurers or self-insurers, third party administrators, and all employers that sponsor or contribute to group health plans or large group health plans." 42 C.F.R. § 411.21.



    CONTACTS

    Media

    ICR, Inc.

    [email protected]

    Investors

    [email protected]



    Primary Logo

    Get the next $LIFW alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LIFW
    $PLTR

    CompanyDatePrice TargetRatingAnalyst
    Palantir Technologies Inc.
    $PLTR
    8/5/2025$160.00Sell → Hold
    Deutsche Bank
    Palantir Technologies Inc.
    $PLTR
    7/25/2025$170.00Overweight
    Piper Sandler
    Palantir Technologies Inc.
    $PLTR
    7/16/2025$135.00Underperform → Neutral
    Mizuho
    Palantir Technologies Inc.
    $PLTR
    4/1/2025$90.00Neutral
    Daiwa Securities
    Palantir Technologies Inc.
    $PLTR
    3/5/2025Underperform → Mkt Perform
    William Blair
    Palantir Technologies Inc.
    $PLTR
    2/20/2025$141.00Buy
    Loop Capital
    Palantir Technologies Inc.
    $PLTR
    2/4/2025$60.00 → $95.00Equal-Weight → Overweight
    Morgan Stanley
    Palantir Technologies Inc.
    $PLTR
    1/23/2025$75.00 → $90.00Outperform
    Wedbush
    More analyst ratings

    $LIFW
    $PLTR
    SEC Filings

    View All

    SEC Form 144 filed by Palantir Technologies Inc.

    144 - Palantir Technologies Inc. (0001321655) (Subject)

    8/22/25 4:11:13 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Palantir Technologies Inc.

    144 - Palantir Technologies Inc. (0001321655) (Subject)

    8/20/25 6:08:26 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Palantir Technologies Inc.

    144 - Palantir Technologies Inc. (0001321655) (Subject)

    8/20/25 4:20:52 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $LIFW
    $PLTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Palantir Technologies upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Palantir Technologies from Sell to Hold and set a new price target of $160.00

    8/5/25 7:04:41 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Piper Sandler initiated coverage on Palantir Technologies with a new price target

    Piper Sandler initiated coverage of Palantir Technologies with a rating of Overweight and set a new price target of $170.00

    7/25/25 9:07:23 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Palantir Technologies upgraded by Mizuho with a new price target

    Mizuho upgraded Palantir Technologies from Underperform to Neutral and set a new price target of $135.00

    7/16/25 7:50:16 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $LIFW
    $PLTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Surf Air Mobility Appoints Shawn Pelsinger to Board of Directors

    Mr. Pelsinger was formerly the Global Head of Corporate Development & Senior Counsel of Palantir Technologies. Surf Air Mobility Inc. (NYSE:SRFM) ("the Company", "Surf Air Mobility"), a leading regional air mobility platform, announced today the appointment of Shawn Pelsinger to the Company's Board of Directors, effective October 8, 2025. Mr. Pelsinger is currently Chief Legal Officer and Chief Administrative Officer of Acrisure, a global fintech provider of solutions across insurance, reinsurance, payroll, benefits, cybersecurity, and real estate services. Prior to joining Acrisure, Mr. Pelsinger was the Global Head of Corporate Development & Senior Counsel of Palantir Technologies (

    10/8/25 6:30:00 AM ET
    $PLTR
    $SRFM
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics

    DENVER and MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) has selected Palantir Technologies (NASDAQ:PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's iRWD™ near real-time AI powered provider network (‘network') enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently. Access to healthcare data remains a key barrier to unlocking the $868 billion market

    10/6/25 7:00:00 AM ET
    $ONMD
    $PLTR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Computer Software: Prepackaged Software
    Technology

    OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics

    OneMedNet Corporation (NASDAQ:ONMD) has selected Palantir Technologies (NASDAQ:PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's iRWD™ near real-time AI powered provider network ("network") enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently. Access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 20301. OneMedNet is

    10/6/25 6:59:00 AM ET
    $ONMD
    $PLTR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Computer Software: Prepackaged Software
    Technology

    $LIFW
    $PLTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stat Lauren Elaina Friedman sold $149,112 worth of shares (800 units at $186.39), decreasing direct ownership by 1% to 62,087 units (SEC Form 4)

    4 - Palantir Technologies Inc. (0001321655) (Issuer)

    10/7/25 8:02:43 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Director Moore Alexander D. sold $3,680,225 worth of shares (20,000 units at $184.01), decreasing direct ownership by 2% to 1,252,978 units (SEC Form 4)

    4 - Palantir Technologies Inc. (0001321655) (Issuer)

    10/3/25 8:03:09 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Officer Buckley Jeffrey

    4 - Palantir Technologies Inc. (0001321655) (Issuer)

    9/23/25 8:04:28 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $LIFW
    $PLTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Planishek Heather A. bought $1,161,400 worth of shares (10,000 units at $116.14), increasing direct ownership by 21% to 58,006 units (SEC Form 4)

    4 - Palantir Technologies Inc. (0001321655) (Issuer)

    5/12/25 7:57:39 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Ruiz John Hasan bought $12,115 worth of shares (50,000 units at $0.24), increasing direct ownership by 3% to 1,791,406 units (SEC Form 4)

    4 - MSP Recovery, Inc. (0001802450) (Issuer)

    8/28/24 4:05:11 PM ET
    $LIFW
    EDP Services
    Technology

    Chief Executive Officer Ruiz John Hasan bought $100,000 worth of shares (360,620 units at $0.28), increasing direct ownership by 26% to 1,741,406 units (SEC Form 4)

    4 - MSP Recovery, Inc. (0001802450) (Issuer)

    8/22/24 9:10:23 AM ET
    $LIFW
    EDP Services
    Technology

    $LIFW
    $PLTR
    Leadership Updates

    Live Leadership Updates

    View All

    Surf Air Mobility Appoints Shawn Pelsinger to Board of Directors

    Mr. Pelsinger was formerly the Global Head of Corporate Development & Senior Counsel of Palantir Technologies. Surf Air Mobility Inc. (NYSE:SRFM) ("the Company", "Surf Air Mobility"), a leading regional air mobility platform, announced today the appointment of Shawn Pelsinger to the Company's Board of Directors, effective October 8, 2025. Mr. Pelsinger is currently Chief Legal Officer and Chief Administrative Officer of Acrisure, a global fintech provider of solutions across insurance, reinsurance, payroll, benefits, cybersecurity, and real estate services. Prior to joining Acrisure, Mr. Pelsinger was the Global Head of Corporate Development & Senior Counsel of Palantir Technologies (

    10/8/25 6:30:00 AM ET
    $PLTR
    $SRFM
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    Lambda Appoints Heather Planishek to Board of Directors as Audit Chair

    Industry veteran brings deep financial and operational expertise from Tines and Palantir Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek to its Board of Directors, where she will serve as Audit Chair. Planishek brings extensive experience scaling high-growth technology companies, currently serving as Chief Operating and Financial Officer at Tines, the intelligent workflow platform. She previously served as Chief Accounting Officer at Palantir Technologies Inc. (NASDAQ: PLTR), where she guided the company through a period of significant growth and its transition to the public markets. This press release features multimedia. View the full release h

    9/25/25 8:00:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    New AI Rollouts Signal Shift From Hype to Healthcare Reality

    USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b

    6/24/25 9:45:00 AM ET
    $LLY
    $PHG
    $PLTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Electronics
    Computer Software: Prepackaged Software

    $LIFW
    $PLTR
    Financials

    Live finance-specific insights

    View All

    Palantir Announces Date of Second Quarter 2025 Earnings Release and Webcast

    Palantir Technologies Inc. (NASDAQ:PLTR) announced today that results for its second quarter ended June 30, 2025 will be released on Monday, August 4, 2025, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 3:00 PM MT / 5:00 PM ET. A live webcast and replay will be available at investors.palantir.com, and participants can pre-register here. In addition, shareholders can submit and vote on questions by visiting https://app.saytechnologies.com/palantir-2025-q2. About Palantir Technologies Inc. Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com. View source version on businesswir

    7/14/25 4:05:00 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Palantir Announces Date of First Quarter 2025 Earnings Release and Webcast

    Palantir Technologies Inc. (NASDAQ:PLTR) announced today that results for its first quarter ended March 31, 2025 will be released on Monday, May 5, 2025, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 3:00 PM MT / 5:00 PM ET. A live webcast and replay will be available at investors.palantir.com, and participants can pre-register here. In addition, shareholders can submit and vote on questions by visiting https://app.saytechnologies.com/palantir-2025-q1. About Palantir Technologies Inc. Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com. View source version on businesswire.com: h

    4/14/25 4:05:00 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Surf Air Mobility Reports Fourth Quarter and Full Year 2024 Financial Results

    Fourth Quarter Revenue of $28.05 Million Rose 5% Compared with Revenue of $26.8 Million in the Prior Year, Exceeding Expectations of $25 - $28 Million Fourth Quarter Adjusted EBITDA Loss of $6.9 Million Improved by $11.5 Million, or 63%, Versus the Prior Year, Within the Guidance Range of $5 - $8 Million Full Year Revenue of $119.4 Million Rose 6% Compared with Pro Forma Revenue of $112.9 Million in the Prior Year Full Year Adjusted EBITDA Loss of $44.1 Million Improved by $6.8 Million, or 13%, Versus the Prior Year on a Pro-Forma Basis Company Launched SurfOS with Six Beta Users Surf Air Mobility Inc. (NYSE:SRFM) (the "Company"), a leading regional air mobility platform, today reporte

    3/18/25 4:05:00 PM ET
    $PLTR
    $SRFM
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    $LIFW
    $PLTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Palantir Technologies Inc.

    SC 13G/A - Palantir Technologies Inc. (0001321655) (Subject)

    11/14/24 5:47:09 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by MSP Recovery Inc.

    SC 13G/A - MSP Recovery, Inc. (0001802450) (Subject)

    11/8/24 8:06:45 PM ET
    $LIFW
    EDP Services
    Technology